ESWI Education Hub provides articles and links to important scientific papers, reviewed by the ESWI Board members, and other online educational activities
ESWI Education Hub provides articles and links to important scientific papers, reviewed by the ESWI Board members, and other online educational activities
Nationality: Romanian
Position: Professor of Infectious Diseases, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Research Field: Infectious Diseases
Dr. Oana Săndulescu is Professor of Infectious Diseases and Head of Department at the Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. She is also a senior specialist in infectious diseases at the National Institute for Infectious Diseases “Prof. Dr. Matei Balș” and holds a second specialty in epidemiology, combining clinical expertise with a population-health perspective.
Her clinical and research work spans viral infections, vaccination, antimicrobial resistance and the implementation of evidence-based infectious disease care. She has a particular interest in respiratory infections, prevention strategies for people at increased risk of severe disease and complications, and the intersection between infectious and non-communicable diseases.
Professor Oana Săndulescu is Chair of the ESCMID Study Group for Viral Hepatitis (ESGVH) and Vice-Chair of the EACS Young Investigator Network (YING). She is Editor-in-Chief of Germs and serves as Associate Editor for several journals in the field. Her past engagements include being Chair of Ecraid’s Clinical Liaison Council, and supporting clinical research collaborations across Europe.
An active educator and mentor in infectious diseases, she supports PhD students, postdoctoral researchers and early-career clinicians in pursuing research careers and engaging in cross-border collaborative networks. She has led and contributed to multiple international projects that strengthen access to best available evidence, advance the evaluation of novel therapeutic agents, and improve patient care across Europe.